VOLUME CIV | AUG 2025

FDA Approves Migraine Prevention Drug for Kids

The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents. In the United States, one in 10 children and adolescents experience migraine, a common but…

Amir Khan

Amir is a Pakistani-Canadian neuroengineer in Toronto, developing brain-computer interfaces to enhance learning. As a volunteer author, he shares insights on how technology can amplify cognitive abilities, drawing from his diverse South Asian-Canadian perspective.

Read Full Article (External Site)

FDA Approves Migraine Prevention Drug for Kids

FDA Approves Gradual Dosing for Alzheimer’s Drug

FDA Approves First Blood Test to Detect Alzheimer’s

FDA Approves Wearable Band for Kids’ Nasal Congestion

FDA Approves Subcutaneous Leqembi for Alzheimer’s